Hermans Kate - Insider Non-Derivative Transactions at Ambrx Biopharma Inc. (AMAM) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 7, 2023, Hermans Kate's relationship to Ambrx Biopharma Inc. (AMAM) is Director, and currently has 85,000 shares of Ordinary Shares.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AMAM insiders.
Data Source: SEC.
Hermans Kate - Insider Non-Derivative Transactions at AMAM
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 8, 2023 | Acquisition -- (Ordinary Shares) | 85000 | 0 | 85000 |